The Webinar on “Strategies to Conduct Clinical Trials effectively in Covid-19 era” organized by CliniMed LifeSciences Pvt. Ltd., Kolkata in association with Indian Society for Clinical Research (ISCR) and Peerless […]readmore
Tags : Exclusive
Shots: Takeda will screen & optimize compounds derived from Debiopharm’s Debio 1454M program to identify candidates for further development to treat IBD and other GI disorders Takeda will pursue the […]readmore
Shots: Accent to receive $55M upfront and $1.1B as co-development option and milestone payment, plus royalties and profit split based on the option to co-develop and co-commercialize RMP-targeting therapies for […]readmore
Shots: BMS to receive $65M up front, including $15M equity investment and is eligible to receive $3B as license fees, discovery, development, regulatory and commercial milestones, in addition to royalty […]readmore
Shots: AbCellera to receive upfront, pre-clinical, clinical & commercial milestones including research payments for the non-COVID-19 targets plus royalties on future sales. Eli Lilly to get rights to develop and […]readmore
Shots: Vividion to receive $135M upfront in cash and is eligible to receive billion dollars preclinical, development and commercial milestones along with royalties on sales of commercialized products resulting from […]readmore
The US FDA’s Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 48 new products so far in 2019. However, there is […]readmore
Shots: MegaPharm to get exclusive commercialization rights for Lurbinectedin in Israel and PharmaMar to retain production rights for the product The focus of the agreement is to strengthen MegaPharm’s oncology […]readmore
Shots: STADA and Xbrane to receive up front and milestones upon approval and launch of the Xlucane in the US and will be eligible to get an equal share of […]readmore
Shots: Shots: Mogrify to receive upfront, development, regulatory and commercial milestones and will be responsible for the discovery & optimization of the cell conversion technology from iPSCs or ESCs to […]readmore